ATE536914T1 - Spezifische cd4+cd25+-regulatorische t-zellen für die hämatopoetische zelltransplantation und immuntoleranz - Google Patents

Spezifische cd4+cd25+-regulatorische t-zellen für die hämatopoetische zelltransplantation und immuntoleranz

Info

Publication number
ATE536914T1
ATE536914T1 AT07726744T AT07726744T ATE536914T1 AT E536914 T1 ATE536914 T1 AT E536914T1 AT 07726744 T AT07726744 T AT 07726744T AT 07726744 T AT07726744 T AT 07726744T AT E536914 T1 ATE536914 T1 AT E536914T1
Authority
AT
Austria
Prior art keywords
regulatory
cells
specific
immune tolerance
cell transplantation
Prior art date
Application number
AT07726744T
Other languages
English (en)
Inventor
David Alexandre Gross
Jean Davoust
Original Assignee
Genethon
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genethon, Centre Nat Rech Scient filed Critical Genethon
Application granted granted Critical
Publication of ATE536914T1 publication Critical patent/ATE536914T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/418—Antigens related to induction of tolerance to non-self
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0637—Immunosuppressive T lymphocytes, e.g. regulatory T cells or Treg

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT07726744T 2006-03-10 2007-03-09 Spezifische cd4+cd25+-regulatorische t-zellen für die hämatopoetische zelltransplantation und immuntoleranz ATE536914T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0650828A FR2898275B1 (fr) 2006-03-10 2006-03-10 Cellules t regulatrices cd4+cd25+specifiques pour la greffe de cellules hematopoietiques et la tolerance immunitaire
PCT/EP2007/052222 WO2007104715A2 (fr) 2006-03-10 2007-03-09 Cellules t regulatrices cd4+cd25+ specifiques pour la greffe de cellules hematopoïetiques et la tolerance immunitaire

Publications (1)

Publication Number Publication Date
ATE536914T1 true ATE536914T1 (de) 2011-12-15

Family

ID=37387347

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07726744T ATE536914T1 (de) 2006-03-10 2007-03-09 Spezifische cd4+cd25+-regulatorische t-zellen für die hämatopoetische zelltransplantation und immuntoleranz

Country Status (7)

Country Link
US (1) US20090220468A1 (de)
EP (1) EP1993574B1 (de)
AT (1) ATE536914T1 (de)
CA (1) CA2643580A1 (de)
ES (1) ES2378164T3 (de)
FR (1) FR2898275B1 (de)
WO (1) WO2007104715A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008017517A1 (en) 2006-08-11 2008-02-14 Life Sciences Research Partners Vzw Immunogenic peptides and their use in immune disorders
WO2009061182A1 (en) * 2007-11-05 2009-05-14 Leiden University Medical Center Hla class ii pi4k2b mhags and application thereof
US20120009678A1 (en) 2008-02-14 2012-01-12 Jean-Marie Saint-Remy Immunotherapy targeting intracellular pathogens
WO2009100505A1 (en) 2008-02-14 2009-08-20 Life Sciences Research Partners Vzw Immunogenic peptides and their use in transplantati
EP2245059B1 (de) 2008-02-14 2017-09-20 Life Sciences Research Partners VZW Cd4+-t-zellen mit zytolytischen eigenschaften
WO2009101204A2 (en) 2008-02-14 2009-08-20 Life Sciences Research Partners Vzw Elimination of immune responses to viral vectors
WO2009101205A2 (en) 2008-02-14 2009-08-20 Life Sciences Research Partners Vzw Immunogenic control of tumours and tumour cells
WO2009101206A2 (en) * 2008-02-14 2009-08-20 Life Sciences Research Partners Vzw Strategies to prevent and/or treat immune responses to soluble allofactors
US10023847B2 (en) 2010-11-25 2018-07-17 Imnate Sarl Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
EP3352782B1 (de) 2015-09-25 2021-03-31 ImCyse SA Verbesserte verfahren und verbindungen zur beseitigung von immunreaktionen auf therapeutische mittel
WO2017182528A1 (en) 2016-04-19 2017-10-26 Imcyse Sa Novel immunogenic cd1d binding peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1241249A1 (de) * 2001-03-12 2002-09-18 Gerold Schuler Regulatorische CD4+CD25+ T Zellen aus menschlichem Blut
FR2864546A1 (fr) * 2003-12-24 2005-07-01 Assist Publ Hopitaux De Paris Methode d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations

Also Published As

Publication number Publication date
CA2643580A1 (fr) 2007-09-20
US20090220468A1 (en) 2009-09-03
FR2898275A1 (fr) 2007-09-14
WO2007104715A3 (fr) 2007-12-06
EP1993574B1 (de) 2011-12-14
WO2007104715A2 (fr) 2007-09-20
ES2378164T3 (es) 2012-04-09
FR2898275B1 (fr) 2012-12-14
EP1993574A2 (de) 2008-11-26

Similar Documents

Publication Publication Date Title
WO2007104715A3 (fr) Cellules t regulatrices cd4+cd25+ specifiques pour la greffe de cellules hematopoïetiques et la tolerance immunitaire
CO6311008A2 (es) Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+
MX2019014009A (es) Metodos mejorados para la elaboracion de terapias celulares adoptivas.
CO6561839A2 (es) Alteracion genómica dirigida
MX2020004019A (es) Metodos y composiciones para inmunoterpia sostenida.
IN2012DN02714A (de)
GEP20156230B (en) Forms of rifaximin and usage thereof
MX2013005062A (es) Composiciones pesticidas y procesos relacionados a las mimas.
TR201902529T4 (tr) Bağışıklığı etkileyen besin bileşimi.
PH12012501550A1 (en) Modified tuberculosis antigens
BR112013002811A8 (pt) meios básicos simplificados para cultura celular pluripotente de humano
UY33647A (es) ?agentes de unión a cd33?.
MY175452A (en) Processing materials
MX2013001045A (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
PH12013502686A1 (en) Pesticidal compositions and processes related thereto
WO2019086959A3 (en) Compositions and methods for improved gamete viability and function
IN2014DN03298A (de)
PL399447A1 (pl) Szczepionka do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnazania komórek Treg do wytwarzania szczepionki do leczenia cukrzycy typu 1
CL2008001014A1 (es) Procedimiento para preparar comprimidos de dihidrocloruro de prampipexol.
EP2590652A4 (de) Pharmazeutische zusammensetzungen mit vanoxerin
GB201020671D0 (en) Passive immunotherapy
MY163060A (en) Accelerator composition for elastomers
IN2015DN00962A (de)
ITMI20102345A1 (it) Fullerene funzionalizzato con gruppi ossazolinici o diidroossazinici
TR201818988T4 (tr) Multipl skleroz semptomlarını hafifletmeye yönelik apoaequorin içeren bileşimlere dayalı yöntemler.